BIOPHARMACEUTICALS GO TO MARKET - PATTERNS OF WORLDWIDE DEVELOPMENT

被引:14
作者
BIENZTADMOR, B
机构
来源
BIO-TECHNOLOGY | 1993年 / 11卷 / 02期
关键词
D O I
10.1038/nbt0293-168
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
引用
收藏
页码:168 / &
相关论文
共 14 条
[1]   THE DRUG LAG ISSUE - THE DEBATE SEEN FROM AN INTERNATIONAL PERSPECTIVE [J].
ANDERSSON, F .
INTERNATIONAL JOURNAL OF HEALTH SERVICES, 1992, 22 (01) :53-72
[2]   BIOPHARMACEUTICALS AND CONVENTIONAL DRUGS - CLINICAL SUCCESS RATES [J].
BIENZTADMOR, B ;
DICERBO, PA ;
TADMOR, G ;
LASAGNA, L .
BIO-TECHNOLOGY, 1992, 10 (05) :521-525
[3]  
BIENZTADMOR B, 1992, UNPUB BIOTECHNOLOGY
[4]  
CHAPEKAR MS, 1992, ANGIOGENESIS KEY PRI, P471
[5]  
HUTTON I, 1984, PHARMA PROJECTS
[6]   THE DRUG LAG - AN UPDATE OF NEW DRUG INTRODUCTIONS IN THE UNITED-STATES AND IN THE UNITED-KINGDOM, 1977 THROUGH 1987 [J].
KAITIN, KI ;
MATTISON, N ;
NORTHINGTON, FK ;
LASAGNA, L .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 46 (02) :121-138
[7]  
SHULMAN SR, 1992, FOOD DRUG LAW J, V47, P363
[8]  
WARDELL WM, 1978, CLIN PHARMACOL THER, V24, P499
[9]  
WARDELL WM, 1973, CLIN PHARMACOL THER, V14, P773
[10]  
1991, SCRIP YB, P35